Skip to main content
Atrás
Watch Compare

Skye Bioscience, Inc.

Calidad de datos: 83%
SKYE
NASDAQ Manufacturing Chemicals
$0.75
▼ $0.02 (-2.98%)
6 months return
—
Momentum
Neutral
ROE
-146.18%

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-146.18%
Below sector avg (-54.47%)
ROIC-119.65%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio4.77
Interest CoverageN/A

Valoración

PE (TTM|NTM)
-0.43 | -0.81
Above sector avg (-1.50)
P/B Ratio0.74
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -43.07 M

Price History

Tendencias Financieras

Precio Objetivo de Analistas

8 analistas
Buy
+1000.0%
upside to target
Actual
$0.75
Consensus Target
$8.25
$2.00
Mín
$20.00
Máx
Pronóstico
P/E Futuro
-0.81
EPS Futuro
-$0.95
Ingresos Est.
0.0

Sorpresas de Ganancias

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -$0.32 · Rev Est: 0.0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -$0.28 -$0.45 -$0.32 -$0.37 — —
Estimate -$0.29 -$0.30 -$0.32 -$0.31 -$0.32 -$0.26
Sorpresa +3.45% -48.90% -1.22% -20.19% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -146.18% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -55.92 M
ROE -146.18% ROA -119.64%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -43.07 M
ROIC -119.65% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 4.77
Debt / Equity N/A Current Ratio 4.77
Interest Coverage N/A Asset Turnover N/A
Working Capital 31.56 M Tangible Book Value 32.84 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.43 · EV/EBITDA: N/A
P/E Ratio -0.43 Forward P/E -0.81
P/B Ratio 0.74 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -177.97%
Market Cap 24.20 M Enterprise Value 5.76 M

Per Share

EPS: -1.41 · FCF/Share: -1.29
EPS (Diluted TTM) -1.41 Revenue / Share N/A
FCF / Share -1.29 OCF / Share -1.29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 77.01% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 77.01%
SBC-Adj. FCF -51.14 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -55.92 M -26.57 M -37.64 M -19.48 M -8.52 M
EPS (Diluted) -1.41 -0.73 -5.37 -0.04 -0.02
Gross Profit — — — — —
Operating Income -58.16 M -30.19 M -34.74 M -18.31 M -7.85 M
EBITDA — — — — —
R&D Expenses — — — 6.01 M 2.93 M
SG&A Expenses — — — — —
D&A 723,352.0 298,640.0 — — —
Interest Expense 0.0 749,308.0 906,270.0 665,133.0 769,159.0
Income Tax 5,400.0 10,071.0 3,600.0 6,741.0 2,100.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 28.31 M 72.76 M 11.94 M 9.11 M 9.86 M
Total Liabilities 8.29 M 4.61 M 14.07 M 12.12 M 3.99 M
Shareholders' Equity 20.02 M 68.15 M -2.13 M -3.01 M 5.86 M
Total Debt — — — — —
Cash & Equivalents 5.88 M 68.42 M — — —
Current Assets 27.09 M 70.83 M 11.65 M 8.94 M 9.61 M
Current Liabilities 8.21 M 4.34 M 13.90 M 12.12 M 3.91 M

Comparación con Pares

vs mediana del sector Manufacturing (1605 pares)
Métrica Acción Mediana del Sector
P/E -0.4 -1.5
P/B 0.7 1.6
ROE % -146.2 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock
BRSIX BRSIX
0.07% weight